CellWell record HH-18570
Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease.
Shechter M; Merz CN; Paul-Labrador M; Meisel SR; Rude RK; Molloy MD
The American journal of cardiology ยท 1999
In plain language
In a crossover trial of 42 patients with coronary artery disease already on aspirin, 3 months of oral magnesium reduced a lab measure of platelet-driven clot formation by 35 percent versus placebo, without changing platelet aggregation itself.
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-18570
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.